4//SEC Filing
AHMED NADIM 4
Accession 0000899243-21-040774
CIK 0001789972other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 4:35 PM ET
Size
5.8 KB
Accession
0000899243-21-040774
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2021-10-18+2,710,000→ 2,710,000 totalExercise: $21.12Exp: 2031-10-17→ Common Stock (2,710,000 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 2,710,000 shares of the Issuer's Common Stock, which shall vest on a pro-rated basis commencing on October 18, 2021, with 1/48 of the shares vesting on a monthly basis over four years, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Cullinan Oncology, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001731193
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 4:35 PM ET
- Size
- 5.8 KB